Delivery Order SPE2DB20D1100-SPE2DB25FE3D8
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 29, 2025, for Bridion 500 mg/5 mL vials, with a ceiling value of $35,252.62 under firm fixed-price terms. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, valued at $13,599.02 under firm fixed price terms. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Bridion 200mg/2ml (10 units) with a ceiling value of $24,536.83. This firm fixed-price, competitively awarded delivery order is funded by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by August 15, 2025. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,673.71 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 ml vials on August 21, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $20,061.21 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on July 23, 2025, with completion scheduled for July 24, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $27,945.02 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 ml vials on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- This delivery order, awarded on August 20, 2025, to AmerisourceBergen Drug Corp, procures Bridion 200 mg/2 ml vials totaling $1,677.58 under a firm fixed price arrangement. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a Defense Department organization responsible for pharmaceutical and medical supply distribution to military healthcare systems. The award represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $3,206.55 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Bridion 500 mg/5 mL vials. The contract, which was competitively awarded without set-aside designation, calls for delivery completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $131,234.68 on July 29, 2025, for the supply of Bridion 200mg/2mL (10 units). This competitively awarded, firm fixed price contract is not set-aside and will be completed by August 25, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain division and represents a child delivery order under AmerisourceBergen's larger prime Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Bridion 200 mg/2 mL vials with a contract value of $27,818.98. This firm fixed-price delivery order, which is expected to be completed by August 26, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement. The award was competitively awarded with no set-aside designation and will be performed at the company's corporate office...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE3D8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $60,425.21 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, and the product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems through its comprehensive pharmaceutical supply portfolio. The company's extensive federal contract history with the Defense Logistics Agency demonstrates its capability to deliver diverse medical commodities, including brand-name and generic medications, vaccines, and specialized healthcare supplies across multiple therapeutic areas. This delivery order for Bridion, a neuromuscular reversal agent used in anesthesia management, exemplifies the company's role in supporting military medical readiness and healthcare operations through the DLA's global pharmaceutical supply network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.4k | 8/27/25 |